Induced Sputum for Assessment of Airway Inflammation in Patients with Copd, Asthma and Asthma-like Symptoms

نویسندگان

  • Paula Rytilä
  • Lauri A. Laitinen
  • Markku M. Nieminen
  • Henrik Riska
  • Ratko Djukanovic
چکیده

.................................................................................................................. 9 INTRODUCTION ...................................................................................................... 10 REVIEW OF THE LITERATURE ........................................................................... 11 DEFINITIONS ............................................................................................................ 11 Chronic obstructive pulmonary disease (COPD) ................................................ 11 Asthma ................................................................................................................. 11 Asthma-like symptoms, chronic cough with eosinophilic bronchitis ................. 12 ASSESSMENT OF AIRWAY INFLAMMATION ................................................... 13 Direct measurement of airway inflammation ...................................................... 13 Indirect measurement of airway inflammation ................................................... 16 INDUCED SPUTUM ................................................................................................. 17 Sputum induction ................................................................................................. 17 Sputum processing ............................................................................................... 19 Spontaneous versus induced sputum ................................................................... 22 Comparison between direct measurements of airway inflammation .................. 23 Clinical applications of assessment of induced sputum ..................................... 23 Induced sputum in children ................................................................................. 23 Induced sputum in other diseases ........................................................................ 24 AIMS OF THE STUDY .............................................................................................. 25 SUBJECTS AND METHODS ................................................................................... 26 STUDY POPULATIONS AND DESIGNS.............................................................. 26 Study I .................................................................................................................. 26 Study II ................................................................................................................. 27 Study III ............................................................................................................... 27 Study IV ............................................................................................................... 28 Study V ................................................................................................................. 30 METHODS ................................................................................................................... 30 Lung function measurements ............................................................................... 30 Skin prick tests ..................................................................................................... 31 Sputum induction ................................................................................................. 32 Sputum processing ............................................................................................... 32 Fluid-phase measurements ................................................................................... 36 Statistical analyses ............................................................................................... 36 RESULTS ..................................................................................................................... 38 CLINICAL CHARACTERISTICS OF SUBJECTS................................................ 38

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Overlap Syndrome in Respiratory Medicine: Asthma and Chronic Obstructive Pulmonary Disease

Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic diseases in the general population. Both are characterized by similar mechanisms: airway inflammation, airway obstruction, and airway hyperresponsiveness. However, the distinction between the two obstructive diseases is not always clear. Multiple epidemiological studies demonstrate that in elderly people with o...

متن کامل

Expression of the Apoptosis Inhibitor Bcl-2 in Sputum Eosinophils in Patients with Asthma

  Background and Objectives: Apoptosis of eosinophils is of significant value in assessing the airway inflammation in patients with asthma. Our purpose was to investigate the degree of expression of the Bcl-2 protein in sputum eosinophils during acute asthma exacerbation and its relationship with exacerbation severity.    Materials and Methods: The study was carried out in Mostafa Khomeini Ho...

متن کامل

Characterization of sputum biomarkers for asthma–COPD overlap syndrome

Asthma-COPD overlap syndrome (ACOS) is a commonly encountered chronic airway disease. However, ACOS is still a consensus-based clinical phenotype and the underlying inflammatory mechanisms are inadequately characterized. To clarify the inflammatory mediatypical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), chitin...

متن کامل

Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.

The pathophysiological features of chronic obstructive pulmonary disease (COPD)-asthma overlap are poorly understood and there has been no study of plasma or sputum biomarkers in overlap patients. In order to clarify the similarity and differences between overlap and COPD or asthma, we have investigated four potential biomarkers of COPD: surfactant protein A (SP-A), soluble receptor for advance...

متن کامل

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap

INTRODUCTION Cell count in induced sputum is a noninvasive biomarker to assess airway inflammation phenotypes. Accordingly, sputum cell counts are extensively used in the treatment of asthma and COPD. Nevertheless, the clinical application of sputum cell counts in patients with asthma-COPD overlap (ACO) remains elusive. The aim of this study was to investigate sputum cell counts in patients wit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2002